Access to diabetes medicines — including insulin affordability and attention to GLP-1 supply in broader metabolic care — remains a kitchen-table health story as fall open-enrollment approaches. Patients report prior-auth friction and pharmacy backorders even when drugs are notionally covered.

Public programs and employers are rewriting formularies under cost pressure. Clinicians warn against unsafe compounding or sharing pens.

Patients should verify benefits with insurers and use manufacturer or clinic patient-assistance programs where eligible. Specialty chronic-disease desk.

Outlets agree air, vaccines, and hospital capacity remain active fall public-health themes.

Advocates emphasize pollution and access gaps; administration allies emphasize affordability and choice — especially on auto rules.

Named reporting on this item includes Associated Press, Washington Examiner, and PBS NewsHour. Prefer those links and primary documents over undated social clips when details shift.

GLP-1 and insulin access questions continue for patients. Coverage rules and supply shape who gets prescriptions filled.

Public-health guidance can change with new case counts or agency notices; use the clinic and agency sources on this item for practical next steps.

Cross-check any sudden claim against the 3 outlets already attached (Associated Press, Washington Examiner, PBS NewsHour) before resharing it.

Case counts, clinic capacity, and drug-access rules are local as well as national. Readers with personal medical questions should use clinician channels, not headline cards.

Details on this Health item can still move during Tuesday dayparts; prefer the linked outlets when a number or meeting time changes.

If a midday update revises a figure, match it across at least two independent outlets before treating a single post as settled.